Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer. (PROPER)
The N+-PROPER Trial: Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer.
Sponsor: University Hospital, Ghent
Terminated
Stopped because of poor accrual in June 2021 after the inclusion of 69 patients
Other terminated trials from University Hospital, Ghent
Other Prostate Cancer trials with similar outcome
Listed as NCT02745587, this PHASE3 trial focuses on Prostate Cancer and remains terminated or withdrawn. Sponsored by University Hospital, Ghent, it has been updated 7 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Feb 2023 — Jul 2024 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Jan 2021 — Feb 2023 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Recruiting PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Ghent
For direct contact, visit the study record on ClinicalTrials.gov .